A NOVEL GLYCOMIC BASED SERUM BIOMARKER (GLYCOCIRRHOTEST) FOR RISK ASSESSMENT OF HEPATOCELLULAR CARCINOMA IN COMPENSATED CIRRHOSIS

(1) Hepatology and Gastroenterology,Ghent University Hospital,Ghent,Belgium;Laboratory of Hepatology,Ghent University,Ghent,Belgium

(2) Inflammation Research Center,Vlaams Instituut voor Biotechnologie,Ghent,Armenia

(3) Department of Hepatology,Beaujon University Hospital,Clichy,France

(4) Inflammation Research Center,Vlaams Instituut voor Biotechnologie,Ghent,Belgium



This item was part of UEG Week 2015

This item can be cited as: United European Gastroenterology Journal; 2015: 2 (Supplement 1)

You may be interested in:

Acute liver failure, organ failure support and prognostic models for decision making
English, Presentation, Hepatobiliary, 2016, Chairman's Choice, Surgery, Postgraduate Teaching
Assessment of liver function in acute liver failure
English, Presentation, Hepatobiliary, Endoscopy, Surgery, Postgraduate Teaching, 2017

Categorisation:

  • Format
    • Abstract
  • Year
    • 2015